Press releasePRNewswire
Transmedics Group
TMDX · NASDAQ
$74.75+$3.15 (+4.40%)TodayMarket closed ·
Prev close $71.60
Latest news
- Press releaseBusiness Wire
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
- Press releasePRNewswire
TransMedics Appoints Fernando Araujo as Chief Financial Officer and Reiterates 2026 Financial Outlook
- Press releasePRNewswire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releasePRNewswire
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
- Press releasePRNewswire
TransMedics to Present at Upcoming September Investor Conferences
- Press releaseGlobe Newswire
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX
- Press releasePRNewswire
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
- Press releasePRNewswire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releaseNewsfile
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
- Press releaseBusiness Wire
TransMedics Group Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of TransMedics Group, Inc. - TMDX
- Press releasePRNewswire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releasePRNewswire
Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
- Press releaseGlobe Newswire
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX
- Press releasePRNewswire
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. - TMDX
- NewsAvi Kapoor
SpaceX, Teradata, Pinterest And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
- News
TransMedics Gr Q2 Adj. EPS $0.44 Misses $0.47 Estimate, Sales $189.948M Beat $183.635M Estimate
- Press releasePRNewswire
TransMedics Reports Second Quarter 2026 Financial Results
- Press releaseBusiness Wire
TransMedics Group, Inc. Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of TransMedics Group, Inc. – TMDX
- Press releasePRNewswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Press releasePRNewswire
TransMedics to Present at the Canaccord Genuity 46th Annual Growth Conference
- Press releasePRNewswire
Did TransMedics Group, Inc. Insiders Breach their Fiduciary Duties to Shareholders?
- Press releasePRNewswire
TransMedics to Report Second Quarter 2026 Financial Results on August 4, 2026
- Press releasePRNewswire
TransMedics Group Announces Completion of Strategic Investment in PAD Aviation service GmbH
- Press releaseGlobe Newswire
Johnson Fistel Investigates TransMedics Group, Inc. (TMDX) After Recent Disclosures Concerning Margin Pressure and NOP Investments
- Press releasePRNewswire
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Press releasePRNewswire
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference
- News
12 Health Care Stocks Moving In Wednesday's Intraday Session
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- NewsAvi Kapoor
Upstart Posts Downbeat Q1 Earnings, Joins Wolfspeed, Arista Networks And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- News
TransMedics Gr Q1 Adj. EPS $0.30 Misses $0.61 Estimate, Sales $173.933M Beat $172.636M Estimate
- Press releasePRNewswire
TransMedics Reports First Quarter 2026 Financial Results
- News
Earnings Scheduled For May 5, 2026
- News
TransMedics Announces Definitive Agreement To Invest In PAD Aviation To Develop Dedicated Organ Transplant Air And Ground Logistics Network In Europe; Terms Not Disclosed
- Press releasePRNewswire
TransMedics Group Announces Intent to Create the First Dedicated European Transplant Logistics Network with Strategic Investment in PAD Aviation service GmbH
- Press releasePRNewswire
The Quiet Rule Change Tilting $10B Toward Medtech's Most Validated Platforms
- Press releasePRNewswire
TransMedics to Provide Update on Ongoing Clinical Programs at the International Society of Heart and Lung Transplantation 2026 Annual Meeting
- NewsErica Kollmann
Bears Pounce On Avis Budget, Lucid, MARA — Short Interest In These 10 Stocks Soars Above 40%
- Press releasePRNewswire
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results
- News
A Glimpse Into The Expert Outlook On TransMedics Group Through 4 Analysts
- Press releasePRNewswire
TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results
- News
Exploring TransMedics Gr's Earnings Expectations
- NewsErica Kollmann
Nvidia, Joby, CoreWeave, Lucid and More Stocks with Earnings This Week
- News
10 Health Care Stocks With Whale Alerts In Today's Session
- NewsAvi Kapoor
Dycom Industries, BellRing Brands, Lumentum And Other Big Stocks Moving Higher On Wednesday
- NewsErica Kollmann
Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks
- NewsAvi Kapoor
RadNet Posts Better-Than-Expected Earnings, Joins Tegna, MeridianLink, Lithium Argentina And Other Big Stocks Moving Higher On Monday
- News
P/E Ratio Insights for TransMedics Group
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.